319 related articles for article (PubMed ID: 37663290)
1. A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer.
Wang C; Kuang W; Zeng J; Ren Y; Liu Q; Sun H; Feng M; Liang D
PeerJ; 2023; 11():e15920. PubMed ID: 37663290
[TBL] [Abstract][Full Text] [Related]
2. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].
Liu Y; Wang YX; Sun XJ; Ting X; Wu R; Liu XD; Liu CR
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):755-765. PubMed ID: 37849256
[No Abstract] [Full Text] [Related]
3. [Analysis of microsatellite instability in endometroid carcinoma with deficient mismatch repair].
Zhang YH; Wu HW; Wang J; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2021 May; 50(5):470-475. PubMed ID: 33915653
[No Abstract] [Full Text] [Related]
4. Investigation of discrepant mismatch repair immunohistochemistry and microsatellite instability polymerase chain reaction test results for gynecologic cancers using next-generation sequencing.
Smithgall MC; Remotti H; Hsiao SJ; Mansukhani M; Liu-Jarin X; Fernandes H
Hum Pathol; 2022 Jan; 119():41-50. PubMed ID: 34666078
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous expression of mismatch repair proteins and interpretation of immunohistochemical results in colorectal cancer and endometrial cancer.
Li X; Zhang S; Zeng J; Song SS; Liu X; Kang W; Liang M; Yang R; Li H; Liang L
Pathol Res Pract; 2023 Aug; 248():154647. PubMed ID: 37437501
[TBL] [Abstract][Full Text] [Related]
6. [Mismatch repair protein expression of colorectal cancer: a retrospective analysis of 3 428 cases].
Liu Y; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Zang FL; Qiu ZQ; Sun BC; Sun Y
Zhonghua Bing Li Xue Za Zhi; 2021 Apr; 50(4):369-375. PubMed ID: 33831997
[No Abstract] [Full Text] [Related]
7. Characterization of mismatch-repair/microsatellite instability-discordant endometrial cancers.
Riedinger CJ; Esnakula A; Haight PJ; Suarez AA; Chen W; Gillespie J; Villacres A; Chassen A; Cohn DE; Goodfellow PJ; Cosgrove CM
Cancer; 2024 Feb; 130(3):385-399. PubMed ID: 37751191
[TBL] [Abstract][Full Text] [Related]
8. Clinical Testing for Mismatch Repair in Neoplasms Using Multiple Laboratory Methods.
Yang RK; Chen H; Roy-Chowdhuri S; Rashid A; Alvarez H; Routbort M; Patel KP; Luthra R; Medeiros LJ; Toruner GA
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230473
[TBL] [Abstract][Full Text] [Related]
9. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.
Timmerman S; Van Rompuy AS; Van Gorp T; Vanden Bempt I; Brems H; Van Nieuwenhuysen E; Han SN; Neven P; Victoor J; Laenen A; Vergote I
Gynecol Oncol; 2020 Apr; 157(1):245-251. PubMed ID: 31980219
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer.
Mendiola M; Heredia-Soto V; Ruz-Caracuel I; Baillo A; Ramon-Patino JL; Escudero FJ; Miguel M; Pelaez-Garcia A; Hernandez A; Feliu J; Hardisson D; Redondo A
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833916
[TBL] [Abstract][Full Text] [Related]
11. Testing for Microsatellite Instability in Colorectal Cancer - a Comparative Evaluation of Immunohistochemical and Molecular Methods.
Vg DR; Nayanar SK; Gopinath V; Philip KJ; Aryadan N; Nair V; Perumal V
Gulf J Oncolog; 2022 May; 1(39):70-78. PubMed ID: 35695349
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of microsatellite instability by next-generation sequencing, MSI PCR and MMR immunohistochemistry in 1942 solid cancers.
Kang SY; Kim DG; Ahn S; Ha SY; Jang KT; Kim KM
Pathol Res Pract; 2022 May; 233():153874. PubMed ID: 35405622
[TBL] [Abstract][Full Text] [Related]
13. High homogeneity of MMR deficiency in ovarian cancer.
Fraune C; Rosebrock J; Simon R; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Büscheck F; Höflmayer D; Schmalfeldt B; Müller V; Wölber L; Witzel I; Paluchowski P; Wilke C; Heilenkötter U; von Leffern I; Clauditz TS; Wilczak W; Sauter G; Steurer S; Burandt E
Gynecol Oncol; 2020 Mar; 156(3):669-675. PubMed ID: 31924330
[TBL] [Abstract][Full Text] [Related]
14. Applicability of the FDA-approved Immunohistochemical Panel for Identification of MMRd Phenotype in Uterine Endometrioid Carcinoma.
Adachi S; Kimata JI; Hanami K; Adachi K; Igarashi T; Liang SG; Ishida Y; Fujino T; Yamazaki K
Appl Immunohistochem Mol Morphol; 2024 Jan; 32(1):24-31. PubMed ID: 37859432
[TBL] [Abstract][Full Text] [Related]
15. Practical guidance for mismatch repair-deficiency testing in endometrial cancer.
Stelloo E; Jansen AML; Osse EM; Nout RA; Creutzberg CL; Ruano D; Church DN; Morreau H; Smit VTHBM; van Wezel T; Bosse T
Ann Oncol; 2017 Jan; 28(1):96-102. PubMed ID: 27742654
[TBL] [Abstract][Full Text] [Related]
16. Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas.
McConechy MK; Talhouk A; Li-Chang HH; Leung S; Huntsman DG; Gilks CB; McAlpine JN
Gynecol Oncol; 2015 May; 137(2):306-10. PubMed ID: 25636458
[TBL] [Abstract][Full Text] [Related]
17. Discordance of microsatellite instability and mismatch repair immunochemistry occurs depending on the cancer type.
Matsubayashi H; Oishi T; Sasaki K; Abe M; Kiyozumi Y; Higashigawa S; Niiya F; Sato J; Ishiwatari H; Imai K; Hotta K; Kishida Y; Takada K; Ono H; Yamazaki K; Yasui H; Kenmotsu H; Kado N; Kagawa H; Shiomi A; Sugiura T; Bando E; Nishimura S; Hatakeyama K; Serizawa M; Harada R; Sugino T
Hum Pathol; 2023 May; 135():54-64. PubMed ID: 36596344
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Study of Microsatellite Instability Testing and Its Comparison With Immunohistochemistry in Gastric Cancers.
Park Y; Nam SK; Seo SH; Park KU; Oh HJ; Park YS; Suh YS; Ahn SH; Park DJ; Kim HH; Lee HS
J Gastric Cancer; 2023 Apr; 23(2):264-274. PubMed ID: 37129151
[TBL] [Abstract][Full Text] [Related]
19. Mismatch Repair Deficiency in Endometrial Cancer: Immunohistochemistry Staining and Clinical Implications.
Doghri R; Houcine Y; Boujelbène N; Driss M; Charfi L; Abbes I; Mrad K; Sellami R
Appl Immunohistochem Mol Morphol; 2019 Oct; 27(9):678-682. PubMed ID: 31567138
[TBL] [Abstract][Full Text] [Related]
20. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]